Altomare, Daniele http://orcid.org/0000-0003-1905-8993
Caprioglio, Camilla
Assal, Frédéric
Allali, Gilles
Mendes, Aline
Ribaldi, Federica
Ceyzeriat, Kelly
Martins, Marta
Tomczyk, Szymon
Stampacchia, Sara
Dodich, Alessandra
Boccardi, Marina
Chicherio, Christian
Frisoni, Giovanni B.
Garibotto, Valentina
Funding for this research was provided by:
Swiss National Science Foundation (320030_169876, 320030_185028)
EU‐EFPIA Innovative Medicines Initiatives 2 Joint Undertaking (115952)
Article History
Received: 28 October 2020
Accepted: 7 February 2021
First Online: 27 February 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local ethic committee (PB 2016-01346).
: Each subject provided a voluntary written informed consent for the participation in the study.
: Daniele Altomare declares that he has no conflict of interest.Camilla Caprioglio declares that she has no conflict of interest.Frédéric Assal declares that he has no conflict of interest.Gilles Allali declares that he has no conflict of interest.Aline Mendes declares that she has no conflict of interest.Federica Ribaldi declares that she has no conflict of interest.Kelly Ceyzeriat declares that she has no conflict of interest.Marta Martins declares that she has no conflict of interest.Szymon Tomczyk declares that he has no conflict of interest.Sara Stampacchia declares that she has no conflict of interest.Alessandra Dodich declares that she has no conflict of interest.Marina Boccardi declares that she has no conflict of interest.Christian Chicherio declares that he has no conflict of interest.Giovanni B. Frisoni reports grants from Alzheimer Forum Suisse, Académie Suisse des Sciences Médicales, Avid Radiopharmaceuticals, Biogen, GE International, Guerbert, Association Suisse pour la Recherche sur l’Alzheimer, IXICO, Merz Pharma, Nestlé, Novartis, Piramal, Roche, Siemens, Teva Pharmaceutical Industries, Vifor Pharma, and Alzheimer’s Association; he has received personal fees from AstraZeneca, Avid Radiopharmaceuticals, Elan Pharmaceuticals, GE International, Lundbeck, Pfizer, and TauRx Therapeutics.Valentina Garibotto received financial support for research through her institution from Siemens Healthineers, GE Healthcare, Life Molecular Imaging, Cerveau Technologies, Roche, Merck.
: This communication reflects the views of the authors and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.